Literature DB >> 1696271

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

G Taraboletti1, D Roberts, L A Liotta, R Giavazzi.   

Abstract

Components of the extracellular matrix have been shown to modulate the interaction of endothelial cells with their microenvironment. Here we report that thrombospondin (TSP), an extracellular matrix component, induces adhesion and spreading of murine lung capillary (LE-II) and bovine aortic (BAEC) endothelial cells. This TSP-induced spreading was inhibited by heparin and fucoidan, known to bind the amino-terminal globular domain of the molecule. In addition, endothelial cells were induced to migrate by a gradient of soluble TSP (chemotaxis). The chemotactic response was inhibited by heparin and fucoidan, as well as by the mAb A2.5, which also binds to the amino-terminal domain. These data are in agreement with our previous observation that the TSP aminoterminal heparin binding region is responsible for the induction of tumor cell spreading and chemotactic motility. The inhibition of chemotaxis and spreading by antibodies against the beta 3 but not the beta 1 chain of the integrin receptor points to a role for the integrins in the interaction of endothelial cells with TSP. We also found that TSP modulates endothelial cell growth. When added to quiescent LE-II cells, it inhibited the mitogenic effects of serum and the angiogenic factor bFGF, in a dose-dependent manner. The inhibition of DNA synthesis detected in the mitogenic assay resulted in a true inhibition of BAEC and LE-II cell growth, as assessed by proliferation assay. This work indicates that TSP affects endothelial cell adhesion, spreading, motility and growth. TSP, therefore, has the potential to modulate the angiogenic process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696271      PMCID: PMC2116188          DOI: 10.1083/jcb.111.2.765

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

1.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells.

Authors:  D D Roberts
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

3.  Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment.

Authors:  D M Haverstick; V M Dixit; G A Grant; W A Frazier; S A Santoro
Journal:  Biochemistry       Date:  1984-11-06       Impact factor: 3.162

4.  Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells.

Authors:  J Varani; B L Riser; L A Hughes; T E Carey; S E Fligiel; V M Dixit
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

5.  Thrombospondin in malignant and non-malignant breast tissue.

Authors:  D A Pratt; W R Miller; J Dawes
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

6.  Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan.

Authors:  P R Kaesberg; W B Ershler; J D Esko; D F Mosher
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Thrombospondin inhibits adhesion of endothelial cells.

Authors:  J Lahav
Journal:  Exp Cell Res       Date:  1988-07       Impact factor: 3.905

8.  Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo.

Authors:  K S O'Shea; V M Dixit
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

9.  Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix.

Authors:  P G Robey; M F Young; L W Fisher; T D McClain
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.

Authors:  J Lawler; R Weinstein; R O Hynes
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  116 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.

Authors:  L Chandrasekaran; C Z He; H Al-Barazi; H C Krutzsch; M L Iruela-Arispe; D D Roberts
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

5.  Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.

Authors:  A Bogdanov; E Marecos; H C Cheng; L Chandrasekaran; H C Krutzsch; D D Roberts; R Weissleder
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

7.  Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-beta1.

Authors:  L Gao; W Qiu; Y Wang; W Xu; J Xu; J Tong
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

8.  Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.

Authors:  A N Qabar; J Bullock; L Matej; P Polverini
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

9.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

10.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

Authors:  L A DiPietro; P J Polverini
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.